Barriers to Adoption of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure: A Mixed‐Methods Study

BACKGROUND: Mineralocorticoid receptor antagonists (MRAs) are the most underutilized pharmacotherapy for heart failure. Minimal data are available on the barriers to MRA adoption from the perspective of prescribing clinicians. METHODS AND RESULTS: A mixed‐methods study consisting of a survey (n=50),...

Descripción completa

Detalles Bibliográficos
Autores principales: Dev, Sandesh, Hoffman, Trisha K., Kavalieratos, Dio, Heidenreich, Paul, Wu, Wen‐Chih, Schwenke, Dawn C., Tracy, Sarah J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943238/
https://www.ncbi.nlm.nih.gov/pubmed/27032719
http://dx.doi.org/10.1161/JAHA.115.002493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943238/
https://www.ncbi.nlm.nih.gov/pubmed/27032719
http://dx.doi.org/10.1161/JAHA.115.002493

Ejemplares similares